Impact of RDI Levels of FOLFOX Chemotherapy on All-Cause Mortality and Cancer-Specific Mortality in Low-Risk Stage III Colon Cancer—Univariable Analysis.
| All-cause mortality (N=237) |
Cancer-specific mortality (N=232) |
||||
|---|---|---|---|---|---|
| RDI | Low RDI% (RDI<selected cutoffs | Crude HR (95% CI) | P | Crude HR (95% CI) | P |
| RDI< 45% vs. RDI≥ 45% | 15.6 | 0.71 (0.21, 2.35) | 0.58 | 0.45 (0.06, 3.42) | 0.44 |
|
| |||||
| RDI< 50% vs. RDI≥ 50% | 19.4 | 1.54 (0.65, 3.62) | 0.32 | 1.20 (0.34, 4.21) | 0.78 |
|
| |||||
| RDI< 55% vs. RDI≥ 55% | 21.9 | 1.37 (0.58, 3.23) | 0.47 | 1.06 (0.30, 3.74) | 0.92 |
|
| |||||
| RDI< 60% vs. RDI≥ 60% | 26.6 | 1.24 (0.55, 2.83) | 0.6 | 0.77 (0.22, 2.72) | 0.68 |
|
| |||||
| RDI< 65% vs. RDI≥ 65% | 30.8 | 1.36 (0.63, 2.94) | 0.44 | 1.21 (0.42, 3.50) | 0.73 |
|
| |||||
| RDI< 70% vs. RDI≥ 70% | 39.7 | 1.08 (0.51, 2.31) | 0.84 | 1.11 (0.40, 3.08) | 0.85 |